PHS
SBUX icon

PFM Health Sciences’s Starbucks SBUX Stock Holding History

PFM Health Sciences’s Portfolio SBUX Stock Details SBUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,327,769
Closed -$77.5M – 107
2017
Q1 		$77.5M Buy
+1,327,769
New +$75.1M 1.94% 15
2014
Q3 		– Sell
-2,062,802
Closed -$79.8M – 70
2014
Q2 		$79.8M Buy
+2,062,802
New +$74.9M 1.6% 23

Other funds holding SBUX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PFM Health Sciences's SBUX Position: Q2 2017 in Review

PFM Health Sciences sold out of Starbucks (SBUX) in Q2 2017, closing a stake of 1,327,769 shares — an estimated $77.5M sold.

PFM Health Sciences first reported a position in SBUX in Q2 2014 and held it in 2 quarters. The position peaked at $79.8M in Q2 2014. 1,440 funds tracked by Wall St. Rank hold SBUX as of Q2 2017.

  • PFM Health Sciences reported no remaining Starbucks position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 1,327,769 Starbucks shares in Q2 2017, an estimated $77.5M.
  • PFM Health Sciences first reported a position in Starbucks in Q2 2014 and held it in 2 quarters.
  • PFM Health Sciences's Starbucks position peaked at $79.8M in Q2 2014.
  • 1,440 funds tracked by Wall St. Rank held Starbucks as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.